Roche Appeals Preliminary Injunction Barring Mircera

Law360, New York (April 10, 2008, 12:00 AM EDT) -- Swiss drugmaker Roche Holding AG is seeking to overturn a preliminary injunction in its ongoing patent dispute with Amgen Inc. that bars Roche from selling anemia drug Mircera in the United States.

Roche filed the notice Wednesday in the U.S. Court of Appeals for the Federal Circuit.

The appeal comes two weeks after Amgen filed a request that U.S. District Judge William G. Young of the District of Massachusetts make the injunction permanent or, at the least, grant the company damages if the court ends up...
To view the full article, register now.